GlaxoSmithKline (GSK)
Add to Watchlists Create an AlertGlaxoSmithKline Market Cap:
142.87B for May 22, 2013GlaxoSmithKline Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 22, 2013 | 142.87B |
| May 21, 2013 | 142.09B |
| May 20, 2013 | 140.90B |
| May 17, 2013 | 140.93B |
| May 16, 2013 | 140.63B |
| May 15, 2013 | 141.58B |
| May 14, 2013 | 139.58B |
| May 13, 2013 | 139.45B |
| May 10, 2013 | 139.31B |
| May 9, 2013 | 136.83B |
| May 8, 2013 | 137.10B |
| May 7, 2013 | 138.29B |
| May 6, 2013 | 137.69B |
| May 3, 2013 | 138.29B |
| May 2, 2013 | 138.80B |
| May 1, 2013 | 138.99B |
| April 30, 2013 | 139.37B |
| April 29, 2013 | 141.47B |
| April 26, 2013 | 140.77B |
| April 25, 2013 | 139.80B |
| April 24, 2013 | 138.58B |
| April 23, 2013 | 137.96B |
| April 22, 2013 | 136.69B |
| April 19, 2013 | 136.13B |
| April 18, 2013 | 135.99B |
| April 17, 2013 | 135.86B |
| April 16, 2013 | 133.27B |
| April 15, 2013 | 132.86B |
| April 12, 2013 | 130.81B |
| April 11, 2013 | 130.95B |
| April 10, 2013 | 128.87B |
| April 9, 2013 | 127.71B |
| April 8, 2013 | 127.03B |
| April 5, 2013 | 126.28B |
| April 4, 2013 | 126.79B |
| April 3, 2013 | 126.76B |
| April 2, 2013 | 126.76B |
| April 1, 2013 | 126.55B |
| March 28, 2013 | 126.60B |
| March 27, 2013 | 125.17B |
| March 26, 2013 | 124.14B |
| March 25, 2013 | 125.06B |
| March 22, 2013 | 125.33B |
| March 21, 2013 | 124.20B |
| March 20, 2013 | 123.87B |
| March 19, 2013 | 123.50B |
| March 18, 2013 | 121.77B |
| March 15, 2013 | 122.26B |
| March 14, 2013 | 122.04B |
| March 13, 2013 | 120.42B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
GSK Market Cap Benchmarks
| Companies | |
|---|---|
| Merck | 140.86B |
| AstraZeneca | 64.64B |
| Eli Lilly and Company | 62.12B |
GSK Market Cap Rankings
| Overall |
98th percentile 34 of 2925 |
| Sector |
99th percentile 6 of 686 in Healthcare |
| Industry |
89th percentile 6 of 55 in Drug Manufacturers - Major |
GSK Market Cap Range, Past 5 Years
| Minimum | 70.73B | Mar 9 2009 |
| Maximum | 142.87B | May 22 2013 |
| Average | 106.27B |
